Progress of ERK Pathway-Modulated Natural Products for Anti-Non-Small-Cell Lung Cancer Activity

Area of Science:

• Oncology
• Pharmacology
• Natural Products Chemistry

Background:

• Lung cancer, particularly non-small cell lung cancer (NSCLC), represents a significant global health burden with increasing incidence and mortality.
• Natural products have historically been a rich source of anticancer drugs, contributing 40% of current therapeutics.
• These compounds offer diverse structures and mechanisms to combat cancer cell proliferation and migration.

Purpose of the Study:

• To review the anticancer activities of various natural compounds against NSCLC.
• To explore their modulation of the ERK-related signaling pathway.
• To provide an outlook on their future role in chemotherapy.

Main Methods:

• Literature review of natural compounds (flavonoids, terpenoids, glycosides, etc.) with anticancer effects on NSCLC.
• Analysis of their mechanisms targeting the ERK signaling pathway.
• Computational prediction of molecular docking affinities with ERK1/ERK2 targets.

Main Results:

• Natural compounds exhibit diverse anticancer activities by regulating multiple biotargets and cell signaling pathways.
• Specific classes of natural products, including flavonoids and terpenoids, show potential in modulating the ERK pathway in NSCLC.
• Computational analysis supports the potential interaction of these compounds with ERK1/ERK2.

Conclusions:

• Natural products are valuable resources for developing novel NSCLC therapeutics.
• Targeting the ERK signaling pathway with natural compounds offers a promising strategy for future antitumor chemotherapy.
• Further research into natural compound combinations and their mechanisms is warranted.